Skip to main content

Advertisement

ADVERTISEMENT

Volume 22 - Issue 4 - April, 2010

Insights

Commentary
03/31/2010
Jaime Ghitelman, MD and Lawrence A. Garcia, MD
Jaime Ghitelman, MD and Lawrence A. G...
Vascular closure devices (VCDs) became available to the interventional cardiology community in the mid-1990s. VCDs were initially created to treat the high rates of access-site bleeding associated with percutaneous coronary intervention (PCI)...
Vascular closure devices (VCDs) became available to the interventional cardiology community in the mid-1990s. VCDs were initially created to treat the high rates of access-site bleeding associated with percutaneous coronary intervention (PCI)...
Vascular closure devices (VCDs)...
03/31/2010
Journal of Invasive Cardiology
Commentary
03/26/2010
Peter C. Block, MD
Peter C. Block, MD
In this issue of the Journal, Ussia and colleagues discuss their experience with using balloon aortic valvuloplasty (BAV) as a “bridge” to transcatheter aortic valve implantation (TAVI) in patients at high risk for TAVI.1 They chose high-risk...
In this issue of the Journal, Ussia and colleagues discuss their experience with using balloon aortic valvuloplasty (BAV) as a “bridge” to transcatheter aortic valve implantation (TAVI) in patients at high risk for TAVI.1 They chose high-risk...
In this issue of the Journal,...
03/26/2010
Journal of Invasive Cardiology
Commentary
03/25/2010
Mohit Gupta, MD and Matthew J. Budoff, MD
Mohit Gupta, MD and Matthew J. Budof...
In the past few years, the use of drug-eluting stents (DES) has had a significant impact on the practice of interventional cardiology. The introduction of DES followed the same course as any newly introduced technique, with the initial period...
In the past few years, the use of drug-eluting stents (DES) has had a significant impact on the practice of interventional cardiology. The introduction of DES followed the same course as any newly introduced technique, with the initial period...
In the past few years, the use...
03/25/2010
Journal of Invasive Cardiology

Feature

Original Contribution
03/31/2010
Shah Azmoon, MD, Anthony L. Pucillo, MD, Wilbert S. Aronow, MD, Ramin Ebrahimi, MD, Joseph Vozzolo, MD, Archana Rajdev, MD, Kumar Kalapatapu, MD, Jae H. Ro, MD, Craig Hjemdahl-Monsen, MD
Shah Azmoon, MD, Anthony L. Pucillo,...
Vascular Complications after Percutaneous Coronary Intervention Following Hemostasis with the Mynx Vascular Closure Device Versus the AngioSeal Vascular Closure Device ABSTRACT: We investigated the prevalence of vascular complications after...
Vascular Complications after Percutaneous Coronary Intervention Following Hemostasis with the Mynx Vascular Closure Device Versus the AngioSeal Vascular Closure Device ABSTRACT: We investigated the prevalence of vascular complications after...
Vascular Complications after...
03/31/2010
Journal of Invasive Cardiology
Original Contribution
03/25/2010
Cataldo Palmieri, MD, Marcello Ravani, MD, Giuseppe Trianni, MD, Jacopo Gianetti, MD, PhD, Marco Vaghetti, MD, Antonio Rizza, MD, Umberto Paradossi, MD, Arton Beqiri, MD, Sergio Berti, MD
Cataldo Palmieri, MD, Marcello Ravan...
Drug-Eluting Stents versus Bare-Metal Stents in Acute ST-Segment Elevation Myocardial Infarction. A Single-Center Experience with Long-Term Follow Up ABSTRACT: Objectives. To compare the efficacy and safety of drug-eluting stents (DES) vs....
Drug-Eluting Stents versus Bare-Metal Stents in Acute ST-Segment Elevation Myocardial Infarction. A Single-Center Experience with Long-Term Follow Up ABSTRACT: Objectives. To compare the efficacy and safety of drug-eluting stents (DES) vs....
Drug-Eluting Stents versus...
03/25/2010
Journal of Invasive Cardiology
03/26/2010
Gian Paolo Ussia, MD*, Davide Capodanno, MD*†, Marco Barbanti, MD*, Marilena Scarabelli, MD*, Sebastiano Immè, MD*, Valeria Cammalleri, MD*, Massimiliano Mulè, MD*, Anna Pistritto, MD*, Patrizia Aruta, MD*, Corrado Tamburino, MD, PhD*†
Gian Paolo Ussia, MD*, Davide Capoda...
ABSTRACT: Objectives. To provide data on feasibility, safety and efficacy of balloon aortic valvuloplasty (BAV) as a bridge to trans-catheter aortic valve implantation (TAVI). Background. There are no data on BAV use as a bridge to TAVI in...
ABSTRACT: Objectives. To provide data on feasibility, safety and efficacy of balloon aortic valvuloplasty (BAV) as a bridge to trans-catheter aortic valve implantation (TAVI). Background. There are no data on BAV use as a bridge to TAVI in...
ABSTRACT: Objectives. To...
03/26/2010
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement